Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect Of LDL-Cholesterol, Lowering Beyond Currently Recommended Minimum Targets On Coronary Heart Disesse (CHD) Recurrence In Patients With Pre-Existing CHD

NCT00327691 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00327691
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00327691 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect Of LDL-Cholesterol, Lowering Beyond Currently Recommended Minimum Targets On Coronary Heart Disesse (CHD) Recurrence In Patients With Pre-Existing CHD
Lead sponsor
Pfizer
Phase
Phase 4
Overall status
Completed
Start date
April 30, 1998
Completion date
August 31, 2004
Enrollment
8,600
Sites
314

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, cerebrovascular accident, coronary heart disease